Mapel, Douglas W., MD, MPH, FCCP

EDUCATION
B.S. (Chemistry) 1984, University of Texas at Arlington
M.D. (Medicine) 1988, University of Texas Medical Branch
M.P.H. (Public Health and Epidemiology) 1994, University of New Mexico

 

PROFESSIONAL LICENSURE AND CERTIFICATION (by examination)
Texas State Board of Medical Examiners #H6404, November 1988 (Inactive)
New Mexico State Board of Medical Examiners #95-290, August 1995
Arizona Medical Board #30994, December 2002
American Board of Internal Medicine (ABIM), Internal Medicine, 1991 (Re-certified through 2011)
ABIM, Subspecialty of Pulmonary Disease, 1994 (Re-certified through 2014)
ABIM, Subspecialty of Critical Care Medicine, 1995 (Re-certified through 2015)



EMPLOYMENT

2009 - Present Adjunct Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
1/03 - Present Critical Care Specialist, Progressive Medical Intensivists, Mesa, AZ
9/02 - Present Medical Director, Lovelace Clinic Foundation, Albuquerque, NM
1/01 - 8/02 Medical Director, Lovelace Scientific Resources, Albuquerque, NM
1/01 - 2002 Associate Scientist, Lovelace Respiratory Research Institute, Albuquerque, NM
1/01 - Present Clinical Assistant Professor of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM
1995 - 2000 Assistant Professor of Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM
1995 - 2000 Pulmonary and Critical Care Consultant, Miners’ Colfax Medical Center, Raton, NM
1995 - 2000 Pulmonary and Critical Care Consultant, Northern Navajo Medical Center (P.H.S.), Shiprock, NM
1992 - 1995 Fellow in Pulmonary and Critical Care Medicine, University of New Mexico Health Sciences Center, Albuquerque, NM
1991 - 1992 Emergency Department Staff Physician, Texas Tech University Health Sciences Center, Lubbock, TX
1988 - 1991 Intern and Resident in Internal Medicine, Texas Tech University Health Sciences Center, Lubbock, TX


PROFESSIONAL AFFILIATIONS
American College of Physicians
American College of Chest Physicians
American Thoracic Society
Greater Albuquerque Medical Association 


 

REPRESENTATIVE PUBLICATIONS

  1. Burney, P., S. Suissa, J. B. Soriano, W. M. Vollmer, G. Viegi, S. D. Sullivan, L. M. Fabbri, D. D. Sin, P. Ernst, D. Coultas, J. Bourbeau, D. W. Mapel, K. Weiss, T. McLaughlin, D. Price, M. C. Sturkenboom, R. Taylor and G. W. Hagan: The Pharmacoepidemiology of COPD: Recent Advances and Methodological Discussion. Eur. Respir. J. Suppl. 43: 1s-44s, 2003.

     

  2. Coultas, D. B. and D. W. Mapel: Undiagnosed Airflow Obstruction: Prevalence and Implications. Curr. Opin. Pulm. Med. 9(2): 96-103, 2003.

     

  3. Mapel, D.: Treatment Implications on Morbidity and Mortality in COPD. Chest 126(2 Suppl.): 150S-158S, 2004.

     

  4. Mapel, D., J. C. Chen, D. George and R. J. Halbert: The Costs of Chronic Obstructive Pulmonary Disease and Its Effects on Managed Care. Manag. Care Interface 17(4): 61-66, 2004.

     

  5. Mapel, D. W., M. Shainline, K. Paez and M. Gunter: Hospital, Pharmacy, and Outpatient Costs for Osteoarthritis and Chronic Back Pain. J. Rheumatol. 31(3): 573-583, 2004.

     

  6. Gagnon, Y. M., A. R. Levy, M. D. Spencer, J. S. Hurley, F. J. Frost, D. W. Mapel and A. H. Briggs: Economic Evaluation of Treating Chronic Obstructive Pulmonary Disease with Inhaled Corticosteroids and Long-Acting ß2-Agonists in a Health Maintenance Organization. Respir. Med. 99(12): 1534-1545, 2005.

     

  7. Mapel, D. W., D. Dedrick and K. Davis: Trends and Cardiovascular Co-morbidities of COPD Patients in the Veterans Administration Medical System, 1991-1999. COPD 2(1): 35-41, 2005.

     

  8. Mapel, D. W., G. P. McMillan, F. J. Frost, J. S. Hurley, M. A. Picchi, E. Lydick and M. D. Spencer: Predicting the Costs of Managing Patients with Chronic Obstructive Pulmonary Disease. Respir. Med. 99(10): 1325-1333, 2005.

     

  9. Doherty, D. E., T. L. Petty, W. Bailey, B. Carlin, R. Cassaburi, K. Christopher, P. Kvale, B. Make, D. Mapel, P. Selecky and J. Tiger: Recommendations of the 6th Long-Term Oxygen Therapy Consensus Conference. Respir. Care 51(5): 519-525, 2006.

     

  10. Mannino, D. M., G. Watt, D. Hole, C. Gillis, C. Hart, A. McConnachie, G. Davey Smith, M. Upton, V. Hawthorne, D. D. Sin, S. F. Man, S. Van Eeden, D. W. Mapel and J. Vestbo: The Natural History of Chronic Obstructive Pulmonary Disease. Eur. Respir. J. 27(3): 627-643, 2006.

     

  11. Mapel, D. W.: Estimating the Cost of COPD—A Matter of Perspective. COPD 3(4): 177-178, 2006.

     

  12. Mapel, D. W., F. J. Frost, J. S. Hurley, H. Petersen, M. Roberts, J. P. Marton and H. Shah: An Algorithm for the Identification of Undiagnosed COPD Cases Using Administrative Claims Data. J. Manag. Care Pharm. 12(6): 457-465, 2006.

     

  13. Mapel, D. W., J. S. Hurley, D. Roblin, M. Roberts, K. J. Davis, R. Schreiner and F. J. Frost: Survival of COPD Patients Using Inhaled Corticosteroids and Long-Acting Beta Agonists. Respir. Med. 100(4): 595-609, 2006.

     

  14. Mapel, D. W., L. S. Nelson, E. Lydick, J. Soriano, M. U. Yood and K. J. Davis: Survival Among COPD Patients Using Fluticasone/Salmeterol in Combination versus Other Inhaled Steroids and Bronchodilators Alone. COPD 4(2): 127-134, 2007.

     

  15. Decramer, M., S. Rennard, T. Troosters, D. W. Mapel, N. Giardino, D. Mannino, E. Wouters, S. Sethi and C. B. Cooper: COPD as a Lung Disease with Systemic Consequences—Clinical Impact, Mechanisms, and Potential for Early Intervention. COPD 5(4): 235-256, 2008.

     

  16. Mapel, D. W., S. B. Robinson, H. B. Dastani, H. Shah, A. L. Phillips and E. Lydick: The Direct Medical Costs of Undiagnosed Chronic Obstructive Pulmonary Disease. Value Health Jan 8 [Epub ahead of print], 2008.

     

  17. Mapel, D. W., S. B. Robinson and E. Lydick: A Comparison of Health-care Costs in Patients with Chronic Obstructive Pulmonary Disease Using Lightweight Portable Oxygen Systems vs. Traditional Compressed-Oxygen Systems. Respir Care 53(9): 1169-1175, 2008.

     

  18. Parshall, M. B., D. W. Mapel, L. Rice, A. Williams and J. O’Reilly: Predictive Validity of Short-Form Health Survey [36 Items] Scales for Chronic Obstructive Pulmonary Disease Exacerbation. Heart Lung 37(5): 356-365, 2008.

     

  19. Shaya, F. T., D. Dongyi, M. O. Akazawa, C. M. Blanchette, J. Wang, D. W. Mapel, A. Dalal and S. M. Scharf: Burden of Concomitant Asthma and COPD in a Medicaid Population. Chest 134(1): 14-19, 2008.

     

  20. Earnshaw, S. R., M. R. Wilson, A. A. Dalal, M. G. Chambers, P. Jhingran, R. Stanford and D. W. Mapel: Cost-Effectiveness of Fluticasone Propionate/Salmeterol (500/50 microg) in the Treatment of COPD. Respir. Med. 103(1): 12-21, 2009.
Home    Animal Respect Code    Site Map    Employee Links    Contact
© 2008 - 2012 Lovelace Respiratory Research Institute